Psychiatry Medical News about Sexual side-effects antidepressants

Become a Member Today!
Register

Most Viewed Abstracts

1. Report Shows Shift in Starting Salaries for Physicians

2. 2008 Exclusive Survey—Earnings: Good news for primary care income

3. Medicare pay-for-reporting effort draws fire from frustrated doctors

4. Debunking Myths in the US Healthcare System

5. Omega-3 fatty acids for bipolar disorder

Your Article Summary

See Latest Articles

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Sexual side-effects of contemporary antidepressants: review
Australian and New Zealand Journal of Psychiatry, 08/12/09

Schweitzer I et al. – There should be direct assessment of sexual function and depression using reliable, validated rating scales before and during treatment. Studies should assess treatment–emergent effects in patients with normal function and resolution of baseline dysfunction over treatment, in both the short and long term. Further research should compare available instruments for measuring sexual function, and include separate analyses of both remitters/non–remitters and male/female subjects.

Methods

Patients with major depressive disorder were identified from the literature using MEDLINE, EMBASE and PsychINFO databases.

Results

Bupropion and duloxetine caused significantly less sexual dysfunction than the SSRIs in short–term studies and reboxetine significantly less in both short– and longer term studies.
Bupropion and agomelatine caused significantly less sexual dysfunction than venlafaxine.
The evidence for mirtazepine having an advantage over the SSRIs is lacking and there are currently insufficient data for desvenlafaxine.
Well–designed comparative studies of contemporary antidepressants with direct assessment of sexual side–effects as the primary outcome measure are scarce.

<< Previous
Reconciling Uncertain Costs and Benefits in Bayes Nets for...

Next >>
Cerebrospinal fluid total tau as a marker of Alzheimer's disease...

Impaired sexual function in women with systemic sclerosis: A cross-sectional study
Arthritis Care and Research, 11/03/09 Relevance Score: 68%

Sexual disorder improvement: a target or a way in treatment of fibromyalgia. A case report and brief review
Modern Rheumatology, 10/07/09 Relevance Score: 66%

Side-effects alert for all statin users as drug is linked to depression and memory loss
Internet Source, 11/10/09 Relevance Score: 65%

Direct agonist activity of tricyclic antidepressants at distinct opioid receptor subtypes
Journal of Pharmacology and Experimental Therapeutics, 10/26/09 Relevance Score: 64%

Duloxetine for treating painful neuropathy or chronic pain
Cochrane Reviews, 10/08/09 Relevance Score: 64%